Literature DB >> 8879697

Tuberculosis in the HIV-positive patient.

E L Corbett1, K M De Cock.   

Abstract

HIV infection is the most potent risk factor known for tuberculosis, which results both from reactivation and progression from recent infection. We review the epidemiology, clinical features, differential diagnosis and management of HIV-associated tuberculosis, probably the most important opportunistic infection associated with HIV worldwide, and one that is communicable to other HIV-negative persons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879697

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN: 0007-1064


  6 in total

1.  Susceptibility to tuberculosis--the importance of the pathogen as well as the host.

Authors:  H McShane
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

2.  Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis.

Authors:  Gabriela Gago; Daniel Kurth; Lautaro Diacovich; Shiou-Chuan Tsai; Hugo Gramajo
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

3.  ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.

Authors:  Daniel G Kurth; Gabriela M Gago; Agustina de la Iglesia; Bernardo Bazet Lyonnet; Ting-Wan Lin; Héctor R Morbidoni; Shiou-Chuan Tsai; Hugo Gramajo
Journal:  Microbiology (Reading)       Date:  2009-05-07       Impact factor: 2.777

4.  Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico.

Authors:  Michele G Velasquez; Rafael Laniado-Laborin; Timothy C Rodwell; Paris Cerecer; Remedios Lozada; Jazmine Cuevas-Mota; Jose Luis Burgos; Richard S Garfein
Journal:  Rev Panam Salud Publica       Date:  2012-07

5.  Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.

Authors:  Toidi Adekambi; Chris C Ibegbu; Ameeta S Kalokhe; Tianwei Yu; Susan M Ray; Jyothi Rengarajan
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

6.  Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.

Authors:  Gareth Betts; Hazel Poyntz; Elena Stylianou; Arturo Reyes-Sandoval; Matthew Cottingham; Adrian Hill; Helen McShane
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.